|
Mean of plasma SM levels according to cardiovascular risk factors. |
||||||
| Controls |
Patients |
|||||
|
|
||||||
| n |
SM in mg/dl |
p-value |
n |
SM in mg/dl |
p-value |
|
|
|
||||||
| Sex |
||||||
| female |
121 |
44.7 ± 1.2 |
0.398 |
279 |
51.3 ± 1.25 |
0.210 |
| male |
323 |
43.9 ± 1.21 |
823 |
50.3 ± 1.24 |
||
| Diabetes mell. |
||||||
| - |
428 |
43.9 ± 1.21 |
<0.001 |
863 |
50.7 ± 1.24 |
0.362 |
| + |
16 |
52.8 ± 1.26 |
239 |
49.9 ± 1.26 |
||
| Hypertension |
||||||
| - |
317 |
44.0 ± 2.29 |
0.628 |
309 |
51.5 ± 1.25 |
0.077 |
| + |
127 |
44.4 ± 1.24 |
793 |
50.2 ± 1.25 |
||
| Smoking |
||||||
| - |
395 |
43.9 ± 1.21 |
0.048 |
801 |
50.2 ± 1.24 |
0.057 |
| + |
49 |
46.4 ± 1.21 |
301 |
51.6 ± 1.26 |
||
| Statins |
||||||
| - |
411 |
44.0 ± 1.21 |
0.46 |
690 |
51.0 ± 1.24 |
0.068 |
| + |
28 |
45.3 ± 1.19 |
395 |
49.7 ± 1.26 |
||
| ACE inhibitors |
||||||
| - |
407 |
44.3 ± 1.21 |
0.309 |
575 |
51.3 ± 1.26 |
0.015 |
| + |
37 |
42.8 ± 1.26 |
527 |
49.7 ± 1.23 |
||
| Ejection fraction |
||||||
| <40% |
- |
- |
- |
69 |
50.4 ± 1.24 |
0.325 |
| >40% |
- |
- |
844 |
51.4 ± 1.21 |
||
Schlitt et al. Nutrition & Metabolism 2006 3:5 doi:10.1186/1743-7075-3-5 |
||||||